肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1344-1347.

• 其他肝病 • 上一篇    下一篇

腹腔镜胆总管切开探查术与内镜逆行胰胆管造影术治疗胆总管结石的疗效比较

张家珅, 朱振成, 刘秋华, 张伯, 陆元基   

  1. 215600 张家港 苏州大学附属张家港医院/张家港市第一人民医院肝胆外科
  • 收稿日期:2026-01-14 出版日期:2026-09-30 发布日期:2026-11-16
  • 通讯作者: 陆元基,Email: lu103310@163.com

LCBDE and ERCP for common bile duct stones: a comparative clinical study

Zhang Jiashen, Zhu Zhencheng, Liu Qiuhua, Zhang Bo, Lu Yuanji   

  1. Department of Hepatobiliary Surgery, Zhangjiagang Hospital Affiliated to Soochow University/Zhangjiagang First People's Hospital, Zhangjiagang 215600, China
  • Received:2026-01-14 Online:2026-09-30 Published:2026-11-16
  • Contact: Lu Yuanji,Email: lu103310@163.com

摘要: 目的 比较腹腔镜胆总管切开术(LCBDE)与内镜逆行胰胆管造影术(ERCP)治疗胆总管结石的疗效及安全性。方法 纳入2023年1月至2025年6月张家港市第一人民医院收治的胆总管结石患者102例,其中LCBDE组52例和ERCP组50例。比较两组治疗完整性相关指标、胆道生理结构相关并发症、术后恢复质量及术后6个月随访结局。结果 LCBDE组一次性结石清除率为96.2%(50/52),显著高于ERCP组84.0%(42/50)(P<0.05);术后残余结石率(3.8%比16.0%)、再次干预率(3.8%比18.0%)及治疗失败率(0比8.0%)均低于ERCP组(均P<0.05)。ERCP组Oddi括约肌损伤发生率为22.0%,明显高于LCBDE组(发生率为0)(P<0.05);术后胆管炎(18.0%比3.8%)及胆汁反流性胃炎(14.0%比1.9%)发生率也高于LCBDE组(均P<0.05)。术后ERCP组首次自主进食时间早于LCBDE组,为(24.8±6.7)h比(36.5±8.2)h,住院时间较短,为(6.5±1.1)d比(7.1±1.3)d(均P<0.05)。6个月随访显示,LCBDE组结石复发率(1.9%比12.0%)、胆道相关再入院率(3.8%比16.0%)及再次胆道干预率(1.9%比14.0%)均显著低于ERCP组(均P<0.05)。结论 LCBDE在治疗胆总管结石方面具有较高的一次性结石清除率,更有利于保护胆道生理结构,并可降低中期结石复发及再次干预风险,而ERCP在术后早期恢复方面具有一定优势。

关键词: 胆总管结石, 腹腔镜胆总管切开探查术, 内镜逆行胰胆管造影术

Abstract: Objective To investigate the relative clinical value of laparoscopic common bile duct exploration (LCBDE) and endoscopic retrograde cholangiopancreatography (ERCP) in patients with common bile duct stones by analyzing perioperative outcomes and mid-term follow-up results. Methods According to the different treatment methods, 102 patients with common bile duct stones in Zhangjiagang First People's Hospital from January 2023 to June 2025 were divided into LCBDE group and ERCP group. Parameters related to treatment completeness, complications related to biliary structural and functional integrity, postoperative recovery quality, and outcomes at 6-month follow-up were compared between the two groups. Results The one-stage stone clearance rate was 96.2% (50/52) in the LCBDE group, which was significantly higher than 84.0% (42/50) in the ERCP group (P<0.05). The incidences of residual stones (3.8% vs. 16.0%), repeat intervention (3.8% vs. 18.0%), and treatment failure (0 vs. 8.0%) were all lower in the LCBDE group than in the ERCP group (all P<0.05). Regarding complications related to biliary physiological integrity, the incidence of sphincter of Oddi injury was 22.0% in the ERCP group, significantly higher than 0 in the LCBDE group (P<0.05). The rates of postoperative cholangitis (18.0% vs. 3.8%) and bile reflux gastritis (14.0% vs. 1.9%) were also higher in the ERCP group (all P<0.05). In terms of postoperative recovery, the ERCP group resumed oral intake earlier than the LCBDE group [(24.8±6.7) h vs. (36.5±8.2) h], and had a shorter hospital stay [(6.5±1.1) d vs. (7.1±1.3) d] (both P<0.05). At the 6-month follow-up, the LCBDE group demonstrated significantly lower rates of stone recurrence (1.9% vs. 12.0%), biliary-related readmission (3.8% vs. 16.0%), and repeat biliary intervention rate (1.9% vs. 14.0%) compared with the ERCP group (all P<0.05). Conclusion LCBDE achieves superior one-stage stone clearance, better preserves the physiological structure of the bile duct, and reduces mid-term risks of stone recurrence and re-intervention. ERCP, on the other hand, offers advantages in early postoperative recovery. Both approaches possess specific indications; therefore, treatment selection should be tailored according to individual patient characteristics.

Key words: Common bile duct stones, Laparoscopic common bile duct exploration, Endoscopic retrograde cholangiopancreatography